File Download

There are no files associated with this item.

Supplementary

Conference Paper: A randomised study of lamivudine for prevention of HBV reactivation in HbsAg seropositive patients undergoing cytotoxic chemotherapy.

TitleA randomised study of lamivudine for prevention of HBV reactivation in HbsAg seropositive patients undergoing cytotoxic chemotherapy.
Authors
Lau, GNgan, RHe, MLCheung, MCYiu, HYCheng, HCLie, AKWKung, KFLiang, RHS
Issue Date2002
Citation
The 52nd Annual Meeting of the American Association for Study of Liver Diseases (AASLD 2002), Boston, MA., 1-5 November 2002. How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/101759

 

DC FieldValueLanguage
dc.contributor.authorLau, Gen_HK
dc.contributor.authorNgan, Ren_HK
dc.contributor.authorHe, MLen_HK
dc.contributor.authorCheung, MCen_HK
dc.contributor.authorYiu, HYen_HK
dc.contributor.authorCheng, HCen_HK
dc.contributor.authorLie, AKWen_HK
dc.contributor.authorKung, KFen_HK
dc.contributor.authorLiang, RHSen_HK
dc.date.accessioned2010-09-25T20:03:11Z-
dc.date.available2010-09-25T20:03:11Z-
dc.date.issued2002en_HK
dc.identifier.citationThe 52nd Annual Meeting of the American Association for Study of Liver Diseases (AASLD 2002), Boston, MA., 1-5 November 2002.-
dc.identifier.urihttp://hdl.handle.net/10722/101759-
dc.languageengen_HK
dc.relation.ispartofAnnual Meeting of the American Association for the Study of Liver Diseases, AASLD 2002en_HK
dc.titleA randomised study of lamivudine for prevention of HBV reactivation in HbsAg seropositive patients undergoing cytotoxic chemotherapy.en_HK
dc.typeConference_Paperen_HK
dc.identifier.emailLau, G: gkklau@netvigator.comen_HK
dc.identifier.emailLie, AKW: akwlie@HKUCC.hku.hken_HK
dc.identifier.emailLiang, RHS: rliang@hku.hken_HK
dc.identifier.authorityLiang, RHS=rp00345en_HK
dc.identifier.hkuros67535en_HK

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats